BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Lonza Group Ltd. (LZAGY.PK) Announces New Head of Lonza Life Science Ingredients


12/28/2010 9:38:52 AM

Basel, Switzerland, 28 December 2010 – Lonza announces the appointment of Harry Boot as new Chief Operating Officer for Lonza’s Life Science Ingredients (LSI) sector and member of the Lonza Management Committee. He takes over the position from Stefan Borgas who headed the sector ad interim since June 2010, parallel to his CEO position. Harry Boot will assume the role on 1 March 2011.

Harry brings significant global experience and knowledge to Lonza having served in the process and chemical industry with GE Silicones, GE Plastics, GE Consumer & Industrial and most recently Bluestar/ Blackstone, where he served as Chief Commercial Officer. He has extensive experience managing large organizations and possesses strong sales, marketing and operational experience with an excellent track record. Harry holds a degree in mechanical engineering and an MBA in Finance.

Harry is married, has three children and has resided in Asia since 2005. After a short transition period in Basel, Switzerland, he will relocate back to China.

About Lonza

Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Products and services span its customers’ needs from research to final product manufacture. It is the global leader in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. In addition, Lonza is a leader in cell-based research, endotoxin detection and cell therapy manufacturing. Furthermore, the company is a leading provider of value chemical and biotech ingredients to the nutrition, hygiene, preservation, agro and personal care markets.

Lonza is headquartered in Basel, Switzerland and is listed on the SIX Swiss Exchange. In 2009, the company had sales of CHF 2.690 billion. Further information can be found at www.lonza.com.

For further Information

Lonza Group Ltd Head of Corporate Communications Dominik Werner Tel +41 61 316 8798 Fax +41 61 316 9798 dominik.werner@lonza.com

Lonza Group Ltd Investor Relations Dirk Oehlers Tel +41 61 316 8540 Fax +41 61 316 9540 dirk.oehlers@lonza.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES